Hydantoins/Isoniazid Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Medical warning:
Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
When these two medicines are taken together, isoniazid may cause your body to process your seizure medicine more slowly.
What might happen:
The blood levels of your seizure medicine may increase and cause toxic effects.
What you should do about this interaction:
If you experience nausea, vomiting, confusion, dizziness, or other symptoms, contact your healthcare professional (e.g. doctor or pharmacist.) It may be necessary to measure the blood levels of your seizure medicine. Your doctor may want to adjust the dose.This interaction may be worse if your body processes drugs slowly or if you are also taking PAS.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
- 1.Dilantin (phenytoin sodium) US prescribing information. Pfizer, Inc. March, 2022.
- 2.Miller RR, Porter J, Greenblatt DJ. Clinical importance of the interaction of phenytoin and isoniazid: a report from the Boston Collaborative Drug Surveillance Program. Chest 1979 Mar;75(3):356-8.
- 3.Adole PS, Kharbanda PS, Sharma S. N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study. Indian J Med Res 2016 May;143(5):581-90.
- 4.Adole PS, Singh A, Kharbanda PS, Sharma S. Phenotypic interaction of simultaneously administered isoniazid and phenytoin in patients with tuberculous meningitis or tuberculoma having seizures. Eur J Pharmacol 2013 Aug 15;714(1-3):157-62.
- 5.Noda H, Eto S, Minemoto M, Noda A, Ohno K. Effects of isoniazid and its metabolites on phenytoin biotransformation in isolated rat hepatocytes. Chem Pharm Bull (Tokyo) 1987 Jan;35(1):277-81.
- 6.Johnson J. Letter: Epanutin and isoniazid interaction. Br Med J 1975 Jan 18;1(5950):152.
- 7.Johnson J, Freeman HL. Death due to isoniazid (INH) and phenytoin. Br J Psychiatry 1976 Nov;129:511.
- 8.Witmer DR, Ritschel WA. Phenytoin-isoniazid interaction: a kinetic approach to management. Drug Intell Clin Pharm 1984 Jun;18(6):483-6.
- 9.Yew WW, Lau KS, Ling MH. Phenytoin toxicity in a patient with isoniazid-induced hepatitis. Tubercle 1991 Dec;72(4):309-10.
- 10.Walubo A, Aboo A. Phenytoin toxicity due to concomitant antituberculosis therapy. S Afr Med J 1995 Nov;85(11):1175-6.
- 11.Buttar HS, Wong LT, Moffatt JH. Effect of isoniazid on the metabolism of 14C-diphenylhydantoin in rats. Arch Int Pharmacodyn Ther 1978 Sep; 235(1):9-18.
- 12.MURRAY FJ. Outbreak of unexpected reactions among epileptics taking isoniazid. Am Rev Respir Dis 1962 Nov;86:729-32.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.